Among patients with relapsing-remitting multiple sclerosis (RRMS), those who develop secondary progressive disease (SPMS) have a high symptom burden and increased disability burden, new data have confirmed.
Among patients with relapsing-remitting multiple sclerosis (RRMS), those who develop secondary progressive disease (SPMS) have a high symptom burden and increased disability burden, new data have confirmed.